inflammatory skin diseases oral therapy(4SC Discovery/LEO Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameinflammatory skin diseases oral therapy(4SC Discovery/LEO Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator Companies4SC Discovery Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies4SC Discovery Gmbh
Active IndicationsN/A
Inactive IndicationsDermatitis

Other Information

ATC CodeN/A
Related LinksN/A